Status:
COMPLETED
Post Marketing Surveillance Of Fesoterodine In Filipino Patients With Over Active Bladder
Lead Sponsor:
Pfizer
Conditions:
Over Active Bladder
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational study and will determine the safety profile of fesoterodine in Filipino patients prescribed the drug. This is in compliance with the requirements of the Philippine Food and Dr...
Detailed Description
Sampling method is not applicable in this study. Only patients prescribed Fesoterodine will be enrolled.
Eligibility Criteria
Inclusion
- Over-active bladder
- Prescribed with Fesoterodine
Exclusion
- Hypersensitivity
- Urinary retention
Key Trial Info
Start Date :
February 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2013
Estimated Enrollment :
508 Patients enrolled
Trial Details
Trial ID
NCT01260311
Start Date
February 1 2011
End Date
October 1 2013
Last Update
September 11 2014
Active Locations (37)
Enter a location and click search to find clinical trials sorted by distance.
1
Mary Johnston Hospital, Inc.
Tondo, Manila, Philippines, 1000
2
East Avenue Medical Center
Diliman, Quezon City, National Capital Region, Philippines, 1101
3
The Medical City
Pasig, National Capital Region, Philippines, 1605
4
St. Luke's Medical Center
Quezon City, National Capital Region, Philippines, 1102